in a randomized , double-blind clinical trial , the planned 10-day treatment was unsuccessful in 15 percent of the vancomycin , ticarcillin , and amikacin group ( n = 53 ) , as compared with 38 percent of the group receiving ticarcillin-clavulanate and amikacin ( n = 48 ) ( p = 0.010 ) .
C0040193
ticarcillin
C0370067
ticarcillin-clavulanate